{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"CCND1, a regulator of the cell cycle, is amplified in various cancer types including breast, head and neck, and bladder cancers.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":true,
  "lastUpdate":"11/16/2020",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "26619011",
        "12955092"
      ]
    },
    "description":"The CCND1 P287T is located in the C-terminus of the protein. This mutation has been found in melanoma, uterine, endometrial and cervical cancer (PMID: 12955092). While this mutation is a statistically significant hotspot (PMID: 26619011), this mutation has not yet been functionally characterized.",
    "knownEffect":"Gain-of-function"
  },
  "oncogenic":"Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"P287T",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":595,
    "hgvs":"11:g.69651253C>A",
    "hugoSymbol":"CCND1",
    "id":null,
    "proteinEnd":287,
    "proteinStart":287,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The CCND1 P287T mutation is known to be oncogenic.",
  "vus":false
}